Ghh. Mannaerts et al., Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer, EUR J SUR O, 27(3), 2001, pp. 265-272
Aims: In the treatment of patients with locally advanced primary or locally
recurrent rectal cancer much attention is given to the oncological aspects
. In long-term survivors, urogenital morbidity can have a large effect on t
he quality of life. This study evaluates the functional outcome after multi
modality treatment in these patient groups.
Patients and methods: Between 1994 and August 1999, 55 patients with locall
y advanced primary and 66 patients with locally recurrent rectal cancer wer
e treated with multimodality treatment: i.e. high-dose preoperative externa
l beam radiation therapy, followed by extended surgery and intraoperative r
adiotherapy. The medical records of the 121 patients were reviewed. To asse
ss long-term urogenital morbidity, all patients still alive, with a minimum
followup of 4 months, were asked to fill out a questionnaire about their v
oiding and sexual function. Seventy-six of the 79 currently living patients
(96%) returned the questionnaire (median FU 14 months, range 4-60).
Results: The questionnaire revealed identifiable voiding dysfunction as a n
ew problem in 31% of the male and 58% of the female patients. In 42% of pat
ients after locally advanced primary and 48% after locally recurrent rectal
cancer treatment bladder dysfunction occurred. The preoperative ability to
have an orgasm had disappeared in 50% of the male and 50% of the female pa
tients, and in 45% of patients after locally advanced primary and in 57% af
ter locally recurrent rectal cancer treatment.
Conclusion: Multimodality treatment for locally advanced primary and recurr
ent rectal cancer results in acceptable urogenital dysfunction if weighed b
y the risk of uncontrolled tumour progression. Long-term voiding and sexual
function is decreased in half of the patients. Preoperative counselling of
these patients on treatment-related urogenital morbidity is important. (C)
2001 Harcourt Publishers Ltd.